Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-24 | 2021-07-15 | 141463 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141128 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141125 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141116 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140690 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140687 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140669 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-06-03 | 2021-07-15 | 140387 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-06-03 | 2021-07-15 | 140381 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-06-03 | 2021-07-15 | 140384 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2021-05-20 | 2021-07-15 | 139734 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 0.5MG 50MCG | OINTMENT | Resolved | 2021-04-08 | 2021-07-15 | 137212 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-02-25 | 2021-07-15 | 134746 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-05-27 | 2021-07-09 | 140042 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120229 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120318 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-12-17 | 2021-07-09 | 130301 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Resolved | 2020-12-17 | 2021-07-09 | 130316 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-05-20 | 2021-07-09 | 139740 |
| TEVA-RISPERIDONE | 4.0MG | TABLET | Resolved | 2021-05-20 | 2021-07-09 | 139746 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
| TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104263 |